<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="app1table1" position="float"><label>Appendix 1&#8212;table 1.</label><caption><title>Col. 1, dominant protein in bands A (GDE) or B (GP).</title><p>Col. 2, individual patient identifier. Cols. 3 and 4, number of unique peptides and their sequence coverage, corresponding to the protein named in the first column. Numbers and sequence coverage data are consistent with predominant presence of GDE in band A and GP and SERCA1 in band B. The numbers of GDE and GP peptides in the respective bands are greater in MHS patients, which suggests a greater content that was confirmed with quantitative immunoblotting.</p></caption><table frame="hsides" rules="groups"><thead><tr valign="top"><th>GDE</th><th>Patient ID</th><th>unique peptide count</th><th>protein sequence coverage (%)</th></tr></thead><tbody><tr valign="top"><td/><td>111(MHN)</td><td>10</td><td>6.4</td></tr><tr valign="top"><td/><td>117(MHN)</td><td>5</td><td>3.5</td></tr><tr valign="top"><td/><td>108(MHS)</td><td>18</td><td>13</td></tr><tr valign="top"><td/><td>119(MHS)</td><td>23</td><td>16</td></tr><tr valign="top"><td>GP</td><td>Patient ID</td><td>unique peptide count</td><td>protein sequence coverage (%)</td></tr><tr valign="top"><td/><td>111(MHN)</td><td>46</td><td>57</td></tr><tr valign="top"><td/><td>117(MHN)</td><td>49</td><td>59</td></tr><tr valign="top"><td/><td>108(MHS)</td><td>68</td><td>69</td></tr><tr valign="top"><td/><td>119(MHS)</td><td>62</td><td>65</td></tr></tbody></table></table-wrap>